INSIGHTS | YMF Law Tokyo Japan

Acting on Contradictory Motivations before FDA & USPTO Results in Unenforceable Patent

"Not long after these information exchanges with FDA, Belcher filed its patent application before the USPTO—where, acting on motivations...

York Faulkner

Sep 20, 20215 min read

Plaintiff Bypasses Hague Convention and Serves Complaint & Summons on Chinese Company's U.S. Lawyers

This decision may impose unfortunate consequences, for example, on Japanese companies since on December 21, 2018, Japan formally objected...

York Faulkner

Sep 13, 20216 min read

Exemplary Embodiments Provide Insufficient Written Description for Broad Genus Patent Claims

The Federal Circuit explained that “[f]or genus claims using functional language, like the binding function of the [single chain antibodies]

York Faulkner

Sep 10, 20214 min read

Legal Notice - YMF Law does not practice Japanese law, and the statements presented on the pages of this website are provided for informational purposes only and are not intended to be relied upon as legal advice.